SCHEMBL7118705

SCHEMBL7118705

O=[N+]([O-])c1ccccc1N1CCC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.64
KMT2A Q03164 1/20 0.64
CTSB P07858 1/20 0.60
AR P10275 1/20 0.60
ALDH1A1 P00352 7/20 0.57
MAPT P10636 5/20 0.57
L3MBTL1 Q9Y468 3/20 0.57
CYP1A2 P05177 2/20 0.57
CYP2C19 P33261 2/20 0.57
ALDH1A3 P47895 1/20 0.57
LMNA P02545 5/20 0.56
MAPK1 P28482 4/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
MITF O75030 2/20 0.56
CCR6 P51684 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
GAA P10253 2/20 0.56
POLB P06746 2/20 0.56
GRM5 P41594 1/20 0.54
HSD11B1 P28845 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29937743 0.96 CTSB (0.65) HTTKMT2ACTSBARALDH1A1
SCHEMBL3799173 0.96 CTSB (0.65) HTTKMT2ACTSBARALDH1A1
SCHEMBL29738367 0.94 GAA (0.63) HTTKMT2ACTSBARALDH1A1
SCHEMBL3292356 0.94 GAA (0.63) HTTKMT2ACTSBARALDH1A1
SCHEMBL1274938 0.92 HTT (0.73) HTTKMT2ACTSBARALDH1A1
SCHEMBL12932461 0.89 HTT (0.61) HTTKMT2AALDH1A1MAPTL3MBTL1
SCHEMBL3435076 0.85 CTSB (0.65) HTTKMT2ACTSBARALDH1A1
SCHEMBL3055471 0.85 MAPT (0.60) HTTKMT2ACTSBARALDH1A1
Acetamide SCHEMBL28113497 0.84 ALDH1A1 (0.60) HTTKMT2ACTSBARALDH1A1
SCHEMBL13790192 0.84 HTT (0.63) HTTKMT2ACTSBARALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030216374-A1 Antibiotic oxazolidinone derivatives SYNGENTA LIMITED (GB) 2003-11-20 US disclosed
US-6605630-B1 Active against drug resistant gram positive pathogens SYNGENTA LIMITED (GB) 2003-08-12 US disclosed
EP-1005468-A1 ANTIBIOTIC OXAZOLIDINONE DERIVATIVES ZENECA LIMITED (GB) 2000-06-07 EP disclosed
WO-1999010342-A1 ANTIBIOTIC OXAZOLIDINONE DERIVATIVES ZENECA LIMITED (GB) 1999-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216374-A1 Antibiotic oxazolidinone derivatives OXA1L, HRH1, OGDH HTT 2176/4885KMT2A 3384/4885CTSB 1847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.